U.S. Markets closed

Infinity Pharmaceuticals, Inc. (INFI)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
3.2500-0.0800 (-2.40%)
At close: 4:00PM EDT
3.2500 0.00 (0.00%)
After hours: 07:32PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 35.9800
52 Week Low 30.7800
50-Day Moving Average 33.1685
200-Day Moving Average 33.0990

Share Statistics

Avg Vol (3 month) 31.42M
Avg Vol (10 day) 31.41M
Shares Outstanding 588.65M
Implied Shares Outstanding 6N/A
Float 78.35M
% Held by Insiders 12.16%
% Held by Institutions 153.34%
Shares Short (Apr 29, 2021) 41.93M
Short Ratio (Apr 29, 2021) 41.63
Short % of Float (Apr 29, 2021) 42.23%
Short % of Shares Outstanding (Apr 29, 2021) 42.18%
Shares Short (prior month Mar 30, 2021) 41.18M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:4
Last Split Date 3Sep 12, 2006

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Mar 30, 2021


Profit Margin 0.00%
Operating Margin (ttm)-2,251.36%

Management Effectiveness

Return on Assets (ttm)-29.19%
Return on Equity (ttm)-165.62%

Income Statement

Revenue (ttm)1.76M
Revenue Per Share (ttm)0.03
Quarterly Revenue Growth (yoy)9.10%
Gross Profit (ttm)-26.08M
Net Income Avi to Common (ttm)-41.23M
Diluted EPS (ttm)-0.6760
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)106.76M
Total Cash Per Share (mrq)1.2
Total Debt (mrq)1.31M
Total Debt/Equity (mrq)2.52
Current Ratio (mrq)11.56
Book Value Per Share (mrq)-0.36

Cash Flow Statement

Operating Cash Flow (ttm)-37.43M
Levered Free Cash Flow (ttm)-22.53M